(ACT) Enact Holdings - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29249E1091

Stock: Mortgage, Insurance, Underwriting, Reinsurance

Total Rating 54

Risk 77

Buy Signal 0.14

Insurance - Specialty » Property & Casualty Insurance
Age: 4.4y

Market Cap: 5,866m
Avg Trading Vol: 12.0M USD

ATR: 2.53%
Peers RS (IBD): 86.79

EPS (Earnings per Share)

EPS CAGR: 4.78%
EPS Trend: 33.2%

Last SUE: 0.13
Qual. Beats: 0

Revenue

Rev. CAGR: 3.59%
Rev. Trend: 94.5%

Last SUE: -0.17
Qual. Beats: 0

Dividends

Dividend Yield	2.24%
Yield on Cost 5y	6.23%
Yield CAGR 5y	-9.78%
Payout Consistency	89.3%
Payout Ratio	24.2%

Risk 5d forecast
Volatility	22.3%
Relative Tail Risk	2.03%

Reward TTM
Sharpe Ratio	1.03
Alpha	21.08

Character TTM
Beta	0.372
Beta Downside	0.239

Drawdowns 3y
Max DD	15.33%
CAGR/Max DD	1.66

Description: ACT Enact Holdings January 08, 2026

Enact Holdings, Inc. (NASDAQ: ACT) is a U.S.-based private mortgage insurer that underwrites and assumes guarantees on prime, individually-underwritten residential mortgage loans, provides contract underwriting services to lenders, and offers mortgage-related reinsurance. The firm, formerly Genworth Mortgage Holdings, rebranded in May 2021 and operates as a subsidiary of Genworth Holdings.

Key operating metrics show a 2023 loss-ratio of roughly 31% and a combined ratio near 95%, indicating modest underwriting profitability. The business is highly sensitive to Fed policy; a 25 bp rise in rates typically depresses new loan volumes and compresses premium income. Additionally, the broader U.S. residential mortgage-insurance market has been consolidating, with total premium volume projected to grow 4-5% annually through 2027 as housing affordability pressures increase demand for private coverage.

For a deeper, data-driven view of ACT’s valuation dynamics, you might explore ValueRay’s analyst toolkit.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income: 659.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.52 > 1.0
NWC/Revenue: 496.0% < 20% (prev 483.9%; Δ 12.06% < -1%)
CFO/TA 0.10 > 3% & CFO 704.4m > Net Income 659.8m
Net Debt (200.5m) to EBITDA (893.4m): 0.22 < 3
Current Ratio: 12.32 > 1.5 & < 3
Outstanding Shares: last quarter (148.3m) vs 12m ago -5.53% < -2%
Gross Margin: 72.93% > 18% (prev 0.78%; Δ 7215 % > 0.5%)
Asset Turnover: 18.18% > 50% (prev 18.13%; Δ 0.05% > 0%)
Interest Coverage Ratio: 13.46 > 6 (EBITDA TTM 893.4m / Interest Expense TTM 49.7m)

Altman Z'' 10.00

A: 0.88 (Total Current Assets 6.61b - Total Current Liabilities 536.6m) / Total Assets 6.88b
B: 0.51 (Retained Earnings 3.53b / Total Assets 6.88b)
C: 0.10 (EBIT TTM 669.6m / Avg Total Assets 6.74b)
D: 2.24 (Book Value of Equity 3.49b / Total Liabilities 1.56b)
Altman-Z'' Score: 10.49 = AAA

Beneish M -3.01

DSRI: 0.97 (Receivables 48.6m/48.8m, Revenue 1.22b/1.20b)
GMI: 1.07 (GM 72.93% / 77.97%)
AQI: 0.94 (AQ_t 0.04 / AQ_t-1 0.04)
SGI: 1.02 (Revenue 1.22b / 1.20b)
TATA: -0.01 (NI 659.8m - CFO 704.4m) / TA 6.88b)
Beneish M-Score: -3.01 (Cap -4..+1) = AA

What is the price of ACT shares?

As of February 08, 2026, the stock is trading at USD 43.17 with a total of 402,631 shares traded.
Over the past week, the price has changed by +8.55%, over one month by +7.68%, over three months by +18.15% and over the past year by +29.32%.

Is ACT a buy, sell or hold?

Enact Holdings has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold ACT.

StrongBuy: 1
Buy: 0
Hold: 4
Sell: 0
StrongSell: 0

What are the forecasts/targets for the ACT price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	42.2	-2.2%
Analysts Target Price	42.2	-2.2%
ValueRay Target Price	53.8	24.7%

ACT Fundamental Data Overview February 02, 2026

P/E Trailing = 9.1216
P/E Forward = 8.0321
P/S = 4.7892
P/B = 1.08
Revenue TTM = 1.22b USD
EBIT TTM = 669.6m USD
EBITDA TTM = 893.4m USD
Long Term Debt = 744.1m USD (from longTermDebt, last quarter)
Short Term Debt = 3.88m USD (from shortTermDebt, last fiscal year)
Debt = 744.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 200.5m USD (from netDebt column, last quarter)
Enterprise Value = 4.33b USD (5.87b + Debt 744.1m - CCE 2.28b)
Interest Coverage Ratio = 13.46 (Ebit TTM 669.6m / Interest Expense TTM 49.7m)
EV/FCF = 6.15x (Enterprise Value 4.33b / FCF TTM 704.4m)
FCF Yield = 16.27% (FCF TTM 704.4m / Enterprise Value 4.33b)
FCF Margin = 57.51% (FCF TTM 704.4m / Revenue TTM 1.22b)
Net Margin = 53.87% (Net Income TTM 659.8m / Revenue TTM 1.22b)
Gross Margin = 72.93% ((Revenue TTM 1.22b - Cost of Revenue TTM 331.5m) / Revenue TTM)
Gross Margin QoQ = 71.51% (prev 74.36%)
Tobins Q-Ratio = 0.63 (Enterprise Value 4.33b / Total Assets 6.88b)
Interest Expense / Debt = 1.73% (Interest Expense 12.9m / Debt 744.1m)
Taxrate = 22.08% (46.3m / 209.8m)
NOPAT = 521.7m (EBIT 669.6m * (1 - 22.08%))
Current Ratio = 12.32 (Total Current Assets 6.61b / Total Current Liabilities 536.6m)
Debt / Equity = 0.14 (Debt 744.1m / totalStockholderEquity, last quarter 5.32b)
Debt / EBITDA = 0.22 (Net Debt 200.5m / EBITDA 893.4m)
Debt / FCF = 0.28 (Net Debt 200.5m / FCF TTM 704.4m)
Total Stockholder Equity = 5.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 659.8m / Total Assets 6.88b)
RoE = 12.78% (Net Income TTM 659.8m / Total Stockholder Equity 5.16b)
RoCE = 11.33% (EBIT 669.6m / Capital Employed (Equity 5.16b + L.T.Debt 744.1m))
RoIC = 8.83% (NOPAT 521.7m / Invested Capital 5.91b)
WACC = 6.62% (E(5.87b)/V(6.61b) * Re(7.29%) + D(744.1m)/V(6.61b) * Rd(1.73%) * (1-Tc(0.22)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.98%
[DCF Debug] Terminal Value 83.83% ; FCFF base≈706.7m ; Y1≈733.7m ; Y5≈837.4m
Fair Price DCF = 137.4 (EV 20.05b - Net Debt 200.5m = Equity 19.85b / Shares 144.4m; r=6.62% [WACC]; 5y FCF grow 4.01% → 2.90% )
EPS Correlation: 33.23 | EPS CAGR: 4.78% | SUE: 0.13 | # QB: 0
Revenue Correlation: 94.49 | Revenue CAGR: 3.59% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.17 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=4.66 | Chg30d=+0.021 | Revisions Net=+1 | Growth EPS=+4.0% | Growth Revenue=+4.0%

Additional Sources for ACT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle